Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Population genomics of the invasive malaria vector Anopheles stephensi in Ethiopia.
Acford-Palmer, H; Phelan, J; Manko, E; Tadesse, F; KRISTAN, M; Walker, T; Bousema, T; Messenger, L; CLARK, T; CAMPINO, S;
2023
(2023).
Towards environmental surveillance of the invasive vector species Anopheles stephensi in sub-Saharan Africa.
KRISTAN, M; Acford-Palmer, H; Oliveira Campos, M; COLLINS, E; Phelan, J; Portwood, N; Clarke, S; LINES, J; CLARK, T; Walker, T; CAMPINO, S; Messenger, L;
2023
(2023).
Having malaria at the same time as COVID-19 alters SARS-CoV-2 antibody response and is dependent on age.
MARLAIS, T; DRAKELEY, C;
2023
(2023).
The provision of malaria services in border districts of four countries in Southern Africa: results from a cross-sectional community assessment of malaria border health posts.
Chisenga, M; Dlamini, B; Mwendera, N; Maquina, P; Hamainza, B; Martins, JF; Saute, F; Bock, H; GOSLING, R; Bennett, A; Smith, J; KLEINSCHMIDT, I;
2023
Malaria journal, (2023).22 1 10.1186/s12936-023-04687-z.
IL-27 produced during acute malaria infection regulates Plasmodium-specific memory CD4+ T cells.
MACALINAO, ML; Inoue, S-I; Tsogtsaikhan, S; Matsumoto, H; Bayarsaikhan, G; Jian, J-Y; Kimura, K; Yasumizu, Y; Inoue, T; Yoshida, H; HAFALLA, J; Kimura, D; Yui, K;
2023
EMBO molecular medicine, (2023).15 12 10.15252/emmm.202317713.
Community evaluation of VECTRON™ T500, a broflanilide insecticide, for indoor residual spraying for malaria vector control in central Benin; a two arm non-inferiority cluster randomised trial.
NGUFOR, C; GOVOETCHAN, R; Fongnikin, A; Hueha, C; Ahoga, J; SYME, T; Agbevo, A; Daleb, A; Small, G; Nimmo, D; BRADLEY, J; Aikpon, R; Iyikirenga, L; Osse, R; Tokponnon, F; Padonou, GG;
2023
Scientific reports, (2023).13 1 10.1038/s41598-023-45047-w.
The effect of RTS,S/AS01E and SMC alone or combined on the acquisition of blood stage antimalarial antibody responses.
PATTERSON, C; SOREMEKUN, S; Dicko, A; Ouedraogo, J-B; Zongo, I; Sagara, I; Snell, P; Lee, C; Ockenhouse, C; Ofori-Anyinam, O; Tinto, H; CHANDRAMOHAN, D; GREENWOOD, B; DRAKELEY, C;
2023
(2023).
Estimating the impact of plasmodium falciparum dhfr and dhps mutations on protective efficacy of sulfadoxine-pyrimethamine: evidence from therapeutic efficacy studies and implications for malaria chemoprevention.
MOUSA, A; Cuomo-Dannenburg, G; Thompson, HA; Bell, DJ; D'Alessandro, U; Nahum, A; Barnes, KI; Raman, J; Gosling, R; Alifrangis, M; Hocke, EF; Hansson, HS; Beshir, KB; CHICO, RM; SUTHERLAND, CJ; Chopo-Pizzaro, A; Okell, LC; ROPER, C;
2023
(2023).(4), 5355 109
Estimating the impact of Plasmodium falciparum dhfr and dhps mutations on protective efficacy of sulfadoxine-pyrimethamine: evidence from therapeutic efficacy studies and implications for malaria chemoprevention.
MOUSA, A; Cuomo-Dannenburg, G; Thompson, HA; Bell, DJ; D'Alessandro, U; Nahum, A; Barnes, KI; Raman, J; GOSLING, R; Alifrangis, M; Hocke, EF; Hansson, HS; BESHIR, K; CHICO, RM; SUTHERLAND, CJ; Chopo-Pizzaro, A; Okell, LC; ROPER, C;
2023
(2023).
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial.
Ouédraogo, A; Bougouma, EC; Palacpac, NM Q; Houard, S; Nebie, I; Sawadogo, J; Berges, GD; Soulama, I; Diarra, A; Hien, D; Ouedraogo, AZ; Konaté, AT; Kouanda, S; Myoui, A; Ezoe, S; Ishii, KJ; Sato, T; D'Alessio, F; Leroy, O; Tiono, AB; COUSENS, S; Horii, T; Sirima, SB;
2023
Frontiers in immunology, (2023).14, 10.3389/fimmu.2023.1267372.